Skip to main content
Skip to footer
Menu
Who We Are
Our Focus : Mitral Regurgitation
Our TSMVR Solution
News
Contact
News
Follow Our Latest Developments and Achievements
HighLife Closes a €32 Million Round B Financing
HighLife appoints Dr. Martin Rothman as independent member of the board
HighLife appoints Jose Calle Gordo as Chairman of the Board
HighLife closes €12.3 million financing round led by Sofinnova Partners
HighLife Successfully Initiates its Clinical Study in Europe
HighLife successfully initiates its clinical feasibility phase
1
2
Top
